
Sumit Bhagra, MD
@sumitbhagramd
Chair, Endocrinology @MayoClinicHS #mayoclinic. Tweets (my own) about #diabetes, metabolism, lifestyle & healthcare delivery
ID: 3032128659
12-02-2015 07:01:24
154 Tweet
579 Followers
473 Following




It took almost 4 decades and thousands of dedicated scientists, but GLP-1R agonists are slowly changing the options and improving outcomes for PPL with #T2D #CVD and now #Obesity Julia Belluz Randy J. Seeley, Ph.D. The Obesity Society Obesity Canada vox.com/22553793/gila-… via Vox




Is it how much you eat, when you eat, or just what you eat that matters? #weightloss #obesity #diabetes #T1D #T2D #CVD #inflammation A new review from Satchin Panda Salk Institute #EndocrineReviews Endocrine Society Journals Time Restricted Feeding academic.oup.com/edrv/advance-a…


As requested by Tamar Haspel here is a brief tweetorial on my latest Nature Reviews Genetics review on the #genetics 🧬 of #obesity rdcu.be/cyjVV 🧵👇 1/7





Mayo Clinic has been ranked once again No.1 in #Diabetes & #Endocrinology by U.S. News & World Report for 2022-2023. #MayoEndo ranked #1 for 26 consecutive years! A testament to the dedication of all our team & a renewed commitment to advancing clinical care and research in endocrinology.



How do you know if or when it's OK to use a medication #OffLabel? Sumit Bhagra, MD explains possible benefits, risks and unintended consequences when an on-label use causes a spike in demand. mayoclinichealthsystem.org/hometown-healt…




